[{"orgOrder":0,"company":"Suanfarma","sponsor":"Monteloeder","pharmaFlowCategory":"D","therapeuticArea":"Sleep","country":"SPAIN","productType":"Small molecule","year":"2022","type":"Acquisition","leadProduct":"Lemon Verbena Extract","moa":"GABA A receptor","graph1":"Sleep","graph2":"Approved","graph3":"Suanfarma","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Sleep","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Suanfarma \/ Suanfarma","highestDevelopmentStatusID":"12","companyTruncated":"Suanfarma \/ Suanfarma"}]

Find Clinical Drug Pipeline Developments & Deals by Suanfarma

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
filter

Year

filter

DEALS // DEV.

filter

Country

filter
Sponsor
filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

Therapeutic Area by Lead Product

ForexGraph

Study Phase by Lead Product

ForexGraph

Company by Lead Product

ForexGraph

Top Deals by Deal Size (USD bn)

ForexGraph

01

Lead Product(s) : Lemon Verbena Extract

Therapeutic Area : Sleep

Study Phase : Approved

Recipient : Monteloeder

Deal Size : Undisclosed

Deal Type : Acquisition

Details : The agreement will develop the presence in areas such as weight management, cardiovascular, nutricosmetics, relaxation and sleep enhancement including Relaxplx, which is purified in verbascoside, and is an effective solution to concerns around rest and m...

Product Name : Relaxplx

Product Type : Small molecule

Upfront Cash : Undisclosed

February 06, 2022

Lead Product(s) : Lemon Verbena Extract

Therapeutic Area : Sleep

Highest Development Status : Approved

Recipient : Monteloeder

Deal Size : Undisclosed

Deal Type : Acquisition

Suanfarma